[Risedronate for treatment of osteoporosis].

  • Hiroshi Hagino
  • Published 2009 in
    Nihon rinsho. Japanese journal of clinical…

Abstract

Risedronate is effective and approved for the treatment of osteoporosis in Japan. Risedronate decreases strongly bone resorption and turnover via a potent inhibitory action on osteoclasts. Risedronate was shown to significantly decrease the risk of nonvertebral fractures including hip fractures as well as vertebral fractures in placebo-controlled, 3-year… (More)

Topics

  • Presentations referencing similar topics